In unselected triple negative breast cancers, around 19% mutations were reported in the BRCA1/2 genes including also scattered somatic mutations (15% in BRCA and 3.9% in BRCA2 genes) (Gonzalez-Angulo et al. 2011). The gene discussed is BRCA1; the disease is triple-negative breast carcinoma.